This is not the kind of news many supporters of the placement of Robert F. Kennedy, Jr. in charge of the United States Department of Health and Human Services (HHS) wanted to see come out of the Food and Drug Administration (FDA) now under his purview. Reuters reported Thursday that the FDA had given full approval — an upgrade from the previous emergency use authorization — for a new version of the mRNA coronavirus “vaccine” of drug company Moderna for children from the age of six months to 11 years old who are identified as at increased risk from coronavirus.
Tag: approval
Some things changed in the United States House of Representatives after Republicans gained the majority in January. But, one thing that has remained the same as during the previous years of Democratic leadership is that the House is committed to handing over to the executive branch, even when the executive branch is under the control as now of a president of another party than the House majority, the power to impose more and more sanctions across the world.
Children have virtually no risk of major sickness or death from coronavirus. And experimental coronavirus “vaccines” such as the one produced by the Pfizer and BioNTech do come with major known health risks of their own. Additional potential side effects of these companies’ and other companies’ shots remain unknown given the shots’ unusually rushed rollout.
Nevertheless, on Thursday, Pfizer and BioNTech sought approval from the United States Food and Drug Administration (FDA) for giving their experimental coronavirus vaccine, which is not even a vaccine under the normal meaning of the term, to children ages five through 11. (Approval is already in place for ages 12 and up.) With the Biden administration, from Joe Biden on down, pushing for everyone — including younger children as soon as legally allowed — to receive experimental coronavirus vaccine shots, there will be much pressure on people in the FDA to give an OK to Pfizer and BioNTech’s request.